Jonathan D. Cooper

23.9k total citations · 4 hit papers
342 papers, 17.9k citations indexed

About

Jonathan D. Cooper is a scholar working on Physiology, Molecular Biology and Surgery. According to data from OpenAlex, Jonathan D. Cooper has authored 342 papers receiving a total of 17.9k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Physiology, 91 papers in Molecular Biology and 74 papers in Surgery. Recurrent topics in Jonathan D. Cooper's work include Lysosomal Storage Disorders Research (102 papers), Cellular transport and secretion (45 papers) and Transplantation: Methods and Outcomes (37 papers). Jonathan D. Cooper is often cited by papers focused on Lysosomal Storage Disorders Research (102 papers), Cellular transport and secretion (45 papers) and Transplantation: Methods and Outcomes (37 papers). Jonathan D. Cooper collaborates with scholars based in United Kingdom, United States and Canada. Jonathan D. Cooper's co-authors include F.G. Pearson, D C Turnell, G.A. Patterson, Thomas R.J. Todd, Elbert P. Trulock, Melvyn Goldberg, O.T. Phillipson, J. Cornwall, G.A. Patterson and G. A. Patterson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jonathan D. Cooper

335 papers receiving 17.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease

1995 640 citations Jonathan D. Cooper et al. profile →
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation.

1993 604 citations Jonathan D. Cooper, Thomas M. Egan et al. profile →
mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases

2017 352 citations Michela Palmieri, Rituraj Pal et al. Nature Communications profile →
Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung

1982 336 citations F.G. Pearson, Norman C. Delarue et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jonathan D. Cooper	5.2k	4.9k	4.5k	4.4k	2.7k	342	17.9k
Bradford C. Berk	5.9k 1.1×	2.2k 0.5×	3.6k 0.8×	16.6k 3.8×	2.8k 1.0×	318	29.8k
Paul T. Schumacker	5.3k 1.0×	3.3k 0.7×	2.2k 0.5×	15.0k 3.4×	1.7k 0.6×	213	29.5k
Paul L. Huang	11.8k 2.3×	2.4k 0.5×	3.5k 0.8×	10.0k 2.3×	1.5k 0.5×	260	31.0k
Hiroki Kurihara	10.6k 2.0×	2.4k 0.5×	2.4k 0.5×	9.6k 2.2×	1.9k 0.7×	263	24.9k
Masatsugu Hori	3.0k 0.6×	2.2k 0.4×	5.4k 1.2×	10.7k 2.4×	2.4k 0.9×	537	33.2k
David M. Stern	7.0k 1.3×	2.2k 0.5×	2.2k 0.5×	10.6k 2.4×	2.0k 0.7×	201	32.3k
Takao Shimizu	5.8k 1.1×	1.8k 0.4×	2.3k 0.5×	14.5k 3.3×	1.8k 0.6×	494	28.4k
D. Neil Granger	4.1k 0.8×	1.7k 0.4×	4.4k 1.0×	5.6k 1.3×	894 0.3×	312	23.8k
Peter S. Rabinovitch	5.3k 1.0×	3.0k 0.6×	4.3k 0.9×	11.9k 2.7×	1.5k 0.5×	305	24.6k
Yoshio Yazaki	11.1k 2.1×	2.8k 0.6×	4.5k 1.0×	17.8k 4.0×	2.9k 1.1×	442	35.5k

Countries citing papers authored by Jonathan D. Cooper

Since Specialization

Citations

This map shows the geographic impact of Jonathan D. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan D. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan D. Cooper more than expected).

Fields of papers citing papers by Jonathan D. Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan D. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan D. Cooper. The network helps show where Jonathan D. Cooper may publish in the future.

Co-authorship network of co-authors of Jonathan D. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan D. Cooper. A scholar is included among the top collaborators of Jonathan D. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan D. Cooper. Jonathan D. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dickson, Patricia, et al.. (2025). Neuronal ceroid lipofuscinosis: underlying mechanisms and emerging therapeutic targets. Nature Reviews Neurology. 21(11). 606–622. 1 indexed citations

Rensing, Nicholas, Hemanth R. Nelvagal, Steven Q. Le, et al.. (2025). GABAergic interneurons contribute to the fatal seizure phenotype of CLN2 disease mice. JCI Insight. 10(19). 1 indexed citations

Le, Steven Q., et al.. (2025). Reduced heparan sulfate levels in cerebrospinal fluid reflect brain neuron correction in Sanfilippo B mice. Journal of Clinical Investigation. 135(22).

Rensing, Nicholas, Hemanth R. Nelvagal, Joshua T. Dearborn, et al.. (2023). Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse model. Journal of Clinical Investigation. 133(12). 5 indexed citations

Eaton, Samantha L., Nina M. Rzechorzek, Gerard Thompson, et al.. (2022). Modelling Neurological Diseases in Large Animals: Criteria for Model Selection and Clinical Assessment. Cells. 11(17). 2641–2641. 4 indexed citations

Kan, Shih‐hsin, Steven Q. Le, Jonathan D. Cooper, et al.. (2021). Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome. Molecular Genetics and Metabolism. 133(2). 185–192. 2 indexed citations

Karda, Rajvinder, Rahimin Affandi Abdul Rahim, Andrew M.S. Wong, et al.. (2020). Generation of light-producing somatic-transgenic mice using adeno-associated virus vectors. Scientific Reports. 10(1). 2121–2121. 3 indexed citations

Egeland, Martin, Roger Lawrence, Elizabeth Snella, et al.. (2020). Central nervous system pathology in preclinical MPS IIIB dogs reveals progressive changes in clinically relevant brain regions. Scientific Reports. 10(1). 20365–20365. 9 indexed citations

Palmieri, Michela, Rituraj Pal, Hemanth R. Nelvagal, et al.. (2017). mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nature Communications. 8(1). 14338–14338. 352 indexed citations breakdown →

10.

Wilkinson, Fiona L., Rebecca Holley, Kia Langford‐Smith, et al.. (2012). Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB. PLoS ONE. 7(4). e35787–e35787. 145 indexed citations

11.

Broom, Lauren, et al.. (2010). The RGD‐containing peptide fragment of osteopontin protects tyrosine hydroxylase positive cells against toxic insult in primary ventral mesencephalic cultures and in the rat substantia nigra. Journal of Neurochemistry. 114(6). 1792–1804. 33 indexed citations

12.

Lim, Michael J., et al.. (2006). Upregulation of the pro-inflammatory cytokine IL1 beta in the Neuronal Ceroid Lipofuscinoses. Developmental Medicine & Child Neurology. 48. 6–6. 1 indexed citations

13.

Pontikis, Charlie C., et al.. (2005). The mild neurodegenerative phenotype of CLN3(Delta ex7/8) knock-in mice is accompanied by prominent astrocytosis at the advanced stages of murine JNCL. Neuropathology and Applied Neurobiology. 31(2). 228–228. 1 indexed citations

14.

Vella, Adrian, Deborah J. Smyth, Jonathan D. Cooper, et al.. (2004). Convincing statistical support for association of the Arg620Trp polymorphism in PTPN22 locus with Type 1 diabetes. Diabetologia. 47. 1 indexed citations

15.

Cooper, Jonathan D.. (2003). Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. Current Opinion in Neurology. 16(2). 121–128. 70 indexed citations

16.

Mitchison, Hannah M., et al.. (2000). Targeted disruption of the Cln3 gene provides a mouse model for Batten disease (vol 6, pg 321, 1999). UCL Discovery (University College London).

17.

Martı́nez, Emilio A., Katrina L. Mealey, Anne A. Wooldridge, et al.. (1996). Pharmacokinetics, effects on renal function, and potentiation of atracurium-induced neuromuscular blockade after administration of a high dose of gentamicin in isoflurane-anesthetized dogs. American Journal of Veterinary Research. 57(11). 1623–1626. 8 indexed citations

18.

Leyn, Paul De, Michael W. Marcus, Pieter Wouters, et al.. (1992). Role of bronchial arteries in lung function. The Annals of Thoracic Surgery. 54(2). 396–397. 1 indexed citations

19.

Phillipson, Eliot A., et al.. (1986). PATTERN OF RESPIRATORY MUSCLE ACTIVATION BY PERIPHERAL AND CENTRAL CHEMORECEPTOR STIMULI. Oxford University Research Archive (ORA) (University of Oxford). 45. 1126–1126. 1 indexed citations

20.

Delarue, Norman C., C. R. Woolf, Douglas E. Sanders, et al.. (1977). Surgical treatment for pulmonary emphysema.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 20(3). 222–31. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact